| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |